Polymorphic ventricular tachycardia (Torsade de Pointes) associated with the use of probucol. 1992

D C Gohn, and T W Simmons

UI MeSH Term Description Entries
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016171 Torsades de Pointes A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION. Torsade de Pointes,Pointes, Torsade de,Pointes, Torsades de,de Pointes, Torsade,de Pointes, Torsades

Related Publications

D C Gohn, and T W Simmons
January 1984, Vutreshni bolesti,
D C Gohn, and T W Simmons
June 1988, The British journal of clinical practice,
D C Gohn, and T W Simmons
April 1984, European heart journal,
D C Gohn, and T W Simmons
November 1995, Anesthesia and analgesia,
D C Gohn, and T W Simmons
April 1999, Anesthesia and analgesia,
D C Gohn, and T W Simmons
May 1983, Heart & lung : the journal of critical care,
D C Gohn, and T W Simmons
November 1979, Postgraduate medical journal,
D C Gohn, and T W Simmons
October 1981, Harefuah,
D C Gohn, and T W Simmons
January 1980, Acta cardiologica,
Copied contents to your clipboard!